Clenil and Weakness - a phase IV clinical study of FDA data

Summary:

Weakness is reported as a side effect among people who take Clenil (beclometasone), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Paracetamol, and have Asthma.

The phase IV clinical study analyzes which people have Weakness when taking Clenil. It is created by eHealthMe based on reports of 1,731 people who have side effects when taking Clenil from the FDA, and is updated regularly.

What is Clenil?

Clenil has active ingredients of beclometasone. eHealthMe is studying from 1,761 Clenil users. Check the latest studies of Clenil.

What is Weakness?

Weakness is found to be associated with 3,638 drugs and 6,617 conditions by eHealthMe. Check the latest studies of Weakness.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

1,731 people reported to have side effects when taking Clenil.
Among them, 43 people (2.48%) have Weakness.

Among these 43 people:

How long have people been on Clenil when they have Weakness? *

What is the gender of people who have Weakness when taking Clenil? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Weakness when taking Clenil? *

What are other drugs people take besides Clenil? *

What are other side effects people have besides Weakness? *

Fatigue (feeling of tiredness): 10 people, 23.26%
Cough: 7 people, 16.28%
Tremor (trembling or shaking movements in one or more parts of your body): 7 people, 16.28%
Disturbance In Attention: 7 people, 16.28%
Dyspnea (difficult or laboured breathing): 7 people, 16.28%
Malaise (a feeling of general discomfort or uneasiness): 6 people, 13.95%
Unresponsive To Stimuli: 6 people, 13.95%
Hyporeflexia (a condition of below normal or absent reflexes): 6 people, 13.95%
Chest Pain: 6 people, 13.95%
Locked-In Syndrome (a condition in which a patient is aware and awake but cannot move or communicate verbally due to complete paralysis): 6 people, 13.95%

What are the existing conditions these people have? *

Asthma: 6 people, 13.95%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 4 people, 9.30%
Hypersensitivity: 4 people, 9.30%
Ill-Defined Disorder: 3 people, 6.98%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 3 people, 6.98%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 6.98%
Pain: 3 people, 6.98%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 3 people, 6.98%
Urinary Tract Infection: 2 people, 4.65%
Depression: 2 people, 4.65%

* Approximation only. Some reports may have incomplete information.

Do you take Clenil and have Weakness?

- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clenil:

Clenil (1,761 reports)

Weakness treatments and more:

Weakness (586,877 reports)

Browse all side effects of Clenil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weakness:

Weakness (3,638 drugs)

Browse all the conditions that are associated with Weakness:

Weakness (6,617 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on beclometasone (the active ingredients of Clenil) and Clenil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.